<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11214">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960958</url>
  </required_header>
  <id_info>
    <org_study_id>CiRAD1</org_study_id>
    <nct_id>NCT02960958</nct_id>
  </id_info>
  <brief_title>Metabolome Analysis in Patients With Rheumatoid Arthritis</brief_title>
  <official_title>Metabolome Analysis in Patients With Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate discriminant metabolites in urine from patients with
      rheumatoid arthritis (RA) from healthy individuals. Then we determine if the patient's
      metabolic fingerprint could predict the development or flare-up of RA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compare metabolites between RA patients and healthy individuals.

        1. Collection urine sample

        2. Assessing urine metabolites by 1H NMR spectroscopy

        3. Analyzing the relationships between metabolites and clinical variables
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Metabolic fingerprint of rheumatoid arthritis</measure>
    <time_frame>1 years</time_frame>
    <description>Metabolomic analyses of urine from patients with rheumatoid arthritis, healthy controls and other autoimmune disease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlations between specific metabolites and disease activity/severity of RA</measure>
    <time_frame>1 year</time_frame>
    <description>Identified metabolites and their clinical significances</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>RheumatoId Arthritis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with rheumatoid arthritis and healthy individuals
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with rheumatoid arthritis meet 2010 American College of
             Rheumatology/European League against Rheumatism classification criteria.

        Exclusion Criteria:

          -  Comorbid with other autoimmune diseases

          -  Confirmed with amyloidosis

          -  Chronic kidney disease (estimated GFR &lt; 60 ml/min/1.73m2)

          -  Chronic liver disease

          -  Thyroid disease

          -  Pregnancy

          -  Solid tumor/hematologic malignancy within 5 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jung Hee Koh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St.Mary's hospital, The Catholic university of Korea</affiliation>
  </overall_official>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 16, 2017</lastchanged_date>
  <firstreceived_date>November 8, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Jung Hee Koh</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Rheumatoid arthritis</keyword>
  <keyword>Metabolomics</keyword>
  <keyword>urine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
